•  Focusing on modifiable risk factors, the project aims to reduce the global impact of breast cancer, a significant health challenge worldwide. •  Multidisciplinary experts will conduct a thorough analysis of national cancer plans and design innovative interventions that will be tailored to specific regions.

Research led by the Departments of Dermatology, Pathology and Molecular Genetics of the Hospital Universitari Arnau de Vilanova de Lleida (HUAV) and the Oncological Pathology research group of the Universitat de Lleida (UdL) and the Institute for Research in Biomedicine of Lleida (IRBLleida) has identified …